Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-26-Speech-3-302-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-26"^^xsd:date2
dcterms:Is Part Of	lp_eu:Public health threat of antimicrobial resistance (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20111026.20.3-302-000"2
lpv:hasSubsequent	lp_eu:2011-10-26-Speech-3-303-0002
lpv:speaker	lp:Marisa Matias2
lpv:spokenAs	substitute; Delegation for relations with South Africa (2009-09-16--2014-06-30)3 unknown; Bloco de Esquerda (2009-07-14--2014-06-30)3 member; EUL/NGL (2009-07-14--2012-01-22)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 vice-chair; Delegation for relations with the Mashreq countries (2009-09-17--2014-06-30)3 member; ITRE (2009-07-16--2012-01-18)3 substitute; ENVI (2009-07-16--2012-01-18)3
lpv:translated text	"Mr President, I believe this debate is of paramount importance, and I would like to thank those who took the initiative of holding it. Resistance to antimicrobials and antibiotics, in particular, is a growing problem. The 25 000 deaths that occur annually in the EU cannot be justified by any means, and it is just as critical that many people end up trying to treat their health problems and die due to the cure, because they are affected by resistant bacteria. This is why health care, not being a business, cannot be dependent on interest or lack thereof from the pharmaceutical industry when developing new medicines. This is merely a symptom, and a symptom of two things in particular: firstly, it is a symptom of the lack of public investment in this area and of the abuse of antibiotics; and secondly, and I would like to highlight this in particular, it is a symptom of the food industry and the way it has been using antibiotics. Therefore, as this is a public health problem, an economic problem, a social problem and a clinical problem, we have to go much further than producing new medicines. What is at stake here is new research and new innovation. I apologise for repeating myself, but we should also be able to work better in terms of preventing and moderating our use of antibiotics. All initiatives are therefore welcome; although it is late in the day, they may still be effective."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph